John B. Thomas
Corporate Officer/Principal presso NIRI NY Chapter
Posizioni attive di John B. Thomas
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NIRI NY Chapter | Corporate Officer/Principal | - | - |
Storia della carriera di John B. Thomas
Precedenti posizioni note di John B. Thomas
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Contatto Relazioni con gli Investitori | 01/05/2015 | 01/01/2017 |
| ABBOTT LABORATORIES | Contatto Relazioni con gli Investitori | 01/12/1995 | 01/05/2013 |
| Public Communications Contact | 01/12/1995 | 01/05/2013 | |
| Abbott Fund | Presidente | - | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Contatto Relazioni con gli Investitori | 17/04/2018 | - |
| Public Communications Contact | 17/04/2018 | - | |
| University of Mississippi | Corporate Officer/Principal | - | - |
Formazione di John B. Thomas
| University of Mississippi | Undergraduate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Irlanda | 2 |
Posizioni
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Aziende private | 4 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| NIRI NY Chapter | |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Abbott Fund |
- Borsa valori
- Insiders
- John B. Thomas
- Esperienza
